Is a Recession Coming?

NYSE: SPY | SPDR S&P 500 ETF Trust News, Ratings, and Charts

SPY – More and more economists and respected market commentators are coming forward talking about fears of a looming recession. And yes, recessions and bear markets go hand in hand. Let’s discuss the odds of recession, what this means for the stock market (SPY) and how this should affect your trading strategy at this time. Read on below for more….

(Please enjoy this updated version of my weekly commentary from the Reitmeister Total Return newsletter).

The place to start this discussion is with the following article published last week on CNBC:

Forecasters see growing chance of a recession as Fed hikes rates this year to fight inflation.

This is a monthly survey of economists to measure the average outlook for the US economy. And here are the key excerpts from that article:

“The probability of a recession in the U.S. was raised to 33% in the next 12 months, up 10 percentage points from the Feb. 1 survey… Respondents debated whether the recent surge in commodity prices would prompt the Fed to hike rates faster because it adds to inflation or raise rates less because they reduce growth… The average GDP forecast for this year slipped by 0.8 percentage point but remains at a slightly above-trend 2.8%. The GDP forecast for 2023 dropped by about a half a point from the last survey to 2.4%.”

Your first reaction is probably a sigh of relief that only 1/3rd of economists has this pessimistic outlook. Now the scarier notion is to find out that historically only 40-50% of economists were predicting a recession before it actually occurred. Indeed, it is a very inexact science and why the current level of concern is actually quite high.

Now let’s contemplate this very thoughtful piece from one of my favorite market commentators, John Mauldin: Brace for (Recession) Impact

For the past year Mauldin has urged folks to consider the possibility of 1970’s style stagflation. That is an ugly economic environment where a stagnant economy emerges at the same time as high inflation. And yes at that time it was about surging energy prices (folks my age or older will certainly remember the gas shortages and long lines at the pump across the US).

John originally contemplated the possibility of this happening. Now he fears that the Russia/Ukraine crisis, with related energy shock, was the last piece of the stagflation puzzle.

Is Mauldin right???

That indeed is the $64,000 question (more like $85 trillion question given the size of the world economy).

Now let’s go back to the previous statement…economics is an inexact science. So for as much as I appreciate Mauldin’s contemplation of stagflation…I don’t believe it is a forgone conclusion.

That sentiment is echoed in the previous clips from the economists survey showing the +2.8% GDP growth expectation for this year and +2.4% for next year.

So Reity…why even bring it up?

Because it COULD come true and we would be wise to stay vigilant looking for signs of that potential. That is why we are not back to 100% long the stock market even as we broke above the 200 day moving average today.

I think we are well positioned right now with the following allocations:

77.5% long stocks (currently spread across 10 stocks and 1 ETF)

8.0% Short of Bond Market with ETF (still the best game in town!!!)

7.5% Cash

7.0% Gold with ETF

If the threats of stagflation, world crisis and/or recession grows…then we will get more and more defensive. That playbook includes selling more and more of our long stocks…maybe all of them. Then flipping things around with inverse ETFs to profit from a declining market.

If these threats prove to be nothing more than false boogeymen…and the economy and bull market stay on track, then we will become more aggressively long the stock market.

Just remember that the most bullish happening right now is we still have historically low interest rates making stocks the MUCH BETTER VALUE than bonds. That is no doubt behind the recent bounce as it was behind the March 2020 bounce when the Coronavirus crisis was far from being solved.

This last part explains our bullish bias now even in the midst of an unclear and unsettling environment.

What To Do Next?

Discover my top picks for this hectic market environment.

I am referring to the 10 stocks and 3 ETFs in my Reitmeister Total Return portfolio that firmly beat the market last year. And well ahead of the market once again in 2022 with a gain of +2.57% while most other investors are still licking their wounds.

How is that possible?

The clue is right there in the name: Reitmeister Total Return

Meaning this service was built to find positive returns in all market environments. Not just when the bull is running full steam ahead. Heck, anyone can profit in that environment.

Yet when stocks are trending sideways, or even worse, heading lower…then you need to employ a different set of strategies to be successful.

Come discover what 40 years of investing experience can do you for you.

Plus see get access to my full portfolio of 10 stocks and 3 ETFs that are primed to excel in this unique market environment.

Click Here to Learn More >

Wishing you a world of investment success!


Steve Reitmeister…but everyone calls me Reity (pronounced “Righty”)
CEO, Stock News Network and Editor, Reitmeister Total Return


SPY shares fell $2.41 (-0.54%) in premarket trading Wednesday. Year-to-date, SPY has declined -5.52%, versus a % rise in the benchmark S&P 500 index during the same period.


About the Author: Steve Reitmeister


Steve is better known to the StockNews audience as “Reity”. Not only is he the CEO of the firm, but he also shares his 40 years of investment experience in the Reitmeister Total Return portfolio. Learn more about Reity’s background, along with links to his most recent articles and stock picks. More...


More Resources for the Stocks in this Article

TickerPOWR RatingIndustry RankRank in Industry
SPYGet RatingGet RatingGet Rating
.INXGet RatingGet RatingGet Rating
DIAGet RatingGet RatingGet Rating
IWMGet RatingGet RatingGet Rating
QQQGet RatingGet RatingGet Rating

Most Popular Stories on StockNews.com


:  |  News, Ratings, and Charts

More Pain on the Way for Stocks

Do not let this 2 day rally for the stock market (SPY) fool you. Consider it a temporary relief rally with things lining up for the next leg lower. At the heart of that is the negative consequences that ALWAYS comes with Fed rate hikes. This time is no different with banks being exhibit #1. Read on below to discover Steve Reitmeister’s updated market outlook, trading plan and top picks to stay on the right side of market action.

:  |  News, Ratings, and Charts

This Software Stock Just Flashed a Buy Signal

Shares of cloud software maker Salesforce (CRM) have gained more than 40% over the past three months. Outstanding financial performance and a bullish outlook, with growing AI integration, have recently driven investor sentiment around CRM. Hence, this software stock might be an ideal buy considering its promising growth prospects and high profitability. Keep reading…

:  |  News, Ratings, and Charts

3 Stocks with More Upside Potential

Coupled with macroeconomic headwinds, the sudden regional banking failures have marred investor sentiments. Moreover, amid anticipations of a recession, the existing market volatilities are not likely to subside anytime soon. Given this backdrop, we think the strong growth prospects of Gilead Sciences (GILD), Teva Pharmaceutical (TEVA), and MacroGenics (MGNX) make these stocks wise portfolio additions now. Read on…

:  |  News, Ratings, and Charts

2 Top Stocks That Should Be on Your Radar This Spring

Amidst the turmoil in the banking sector, high inflation, and the Fed’s restrictive monetary policy, the economy faces a threat of recession this year. However, fundamentally strong stocks AbbVie (ABBV) and Salesforce (CRM) might be worth adding to your watchlist. Read more...

:  |  News, Ratings, and Charts

3 Stocks with More Upside Potential

Coupled with macroeconomic headwinds, the sudden regional banking failures have marred investor sentiments. Moreover, amid anticipations of a recession, the existing market volatilities are not likely to subside anytime soon. Given this backdrop, we think the strong growth prospects of Gilead Sciences (GILD), Teva Pharmaceutical (TEVA), and MacroGenics (MGNX) make these stocks wise portfolio additions now. Read on…

Read More Stories

More SPDR S&P 500 ETF Trust (SPY) News View All

Event/Date Symbol News Detail Start Price End Price Change POWR Rating
Loading, please wait...
View All SPY News